165 related articles for article (PubMed ID: 8394726)
41. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances.
Grubb BP; Karas BJ
J Interv Card Electrophysiol; 1998 Dec; 2(4):325-32. PubMed ID: 10027117
[No Abstract] [Full Text] [Related]
42. Consequences of 5-HT re-uptake blockade on postsynaptic 5-HT1A receptor activation: an electrophysiological and neurochemical study in guinea pig dorsal raphe and hippocampus.
Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
Ann N Y Acad Sci; 1998 Dec; 861():272-3. PubMed ID: 9928286
[No Abstract] [Full Text] [Related]
43. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
[TBL] [Abstract][Full Text] [Related]
44. [Why lie about the causes of depression?].
Mulinari S
Lakartidningen; 2011 Sep 21-27; 108(38):1839-40. PubMed ID: 22111217
[No Abstract] [Full Text] [Related]
45. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex.
Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM
Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336
[TBL] [Abstract][Full Text] [Related]
46. [The role of nitrogen oxide in migraine attack].
Stepień A
Neurol Neurochir Pol; 1999; 33(2):435-44. PubMed ID: 10463256
[TBL] [Abstract][Full Text] [Related]
47. Preface. Physiological, pathophysiological and therapeutic aspects of 5-HT mechanisms.
Meneses A
Behav Brain Res; 2008 Dec; 195(1):1. PubMed ID: 18706936
[No Abstract] [Full Text] [Related]
48. Migraine management. New approaches focus on serotonin receptors.
DeRaps PK
Adv Nurse Pract; 1999 May; 7(5):51-5. PubMed ID: 10578735
[No Abstract] [Full Text] [Related]
49. Multiple serotonergic paths to antidepressant efficacy.
Lutz PE
J Neurophysiol; 2013 May; 109(9):2245-9. PubMed ID: 23343901
[TBL] [Abstract][Full Text] [Related]
50. Serotonin and migraine.
Humphrey PP; Feniuk W; Perren MJ; Beresford IJ; Skingle M; Whalley ET
Ann N Y Acad Sci; 1990; 600():587-98; discussion 598-600. PubMed ID: 2252337
[TBL] [Abstract][Full Text] [Related]
51. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
Yamada J; Sugimoto Y
Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
[TBL] [Abstract][Full Text] [Related]
52. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
Dean B; Hayes W; Opeskin K; Naylor L; Pavey G; Hill C; Keks N; Copolov DL
Behav Brain Res; 1996; 73(1-2):169-75. PubMed ID: 8788497
[TBL] [Abstract][Full Text] [Related]
53. Effects of milnacipran on the inhibitory postsynaptic potential in neurons of the rat locus coeruleus.
Kuwahata T; Kidani Y; Ishimatsu M; Akasu T
Kurume Med J; 2004; 51(3-4):185-91. PubMed ID: 15682825
[TBL] [Abstract][Full Text] [Related]
54. Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions.
Shimizu S; Mizuguchi Y; Ohno Y
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):861-9. PubMed ID: 23844689
[TBL] [Abstract][Full Text] [Related]
55. Depression and serotonin: a never ending story.
Marazziti D
Curr Drug Targets; 2013 May; 14(5):513. PubMed ID: 23547753
[No Abstract] [Full Text] [Related]
56. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.
Kumar U; Medel-Matus JS; Redwine HM; Shin D; Hensler JG; Sankar R; Mazarati A
Epilepsia; 2016 Mar; 57(3):506-15. PubMed ID: 26813337
[TBL] [Abstract][Full Text] [Related]
57. Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
[TBL] [Abstract][Full Text] [Related]
58. [Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan].
Hendrix Y; van Zagten MS
Ned Tijdschr Geneeskd; 2005 Apr; 149(16):888-90. PubMed ID: 15868995
[TBL] [Abstract][Full Text] [Related]
59. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
[TBL] [Abstract][Full Text] [Related]
60. Expression and impact of Lsamp neural adhesion molecule in the serotonergic neurotransmission system.
Bregin A; Kaare M; Jagomäe T; Karis K; Singh K; Laugus K; Innos J; Leidmaa E; Heinla I; Visnapuu T; Oja EM; Kõiv K; Lilleväli K; Harro J; Philips MA; Vasar E
Pharmacol Biochem Behav; 2020 Nov; 198():173017. PubMed ID: 32828972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
